98%
921
2 minutes
20
Superficial acral fibromyxoma (SAFM) is a rare benign, slow-growing soft-tissue neoplasm with a predilection for the periungual or subungual regions of the fingers and toes. Although the histopathological and clinical features of SAFM have been extensively described, reports detailing its MRI characteristics remain limited. We present two cases of SAFM with differing MRI features and comparative histopathology. Case 1 was a 38-year-old man with a 2-year history of a painful slow-growing tumor arising on his left second finger. The tumor was hypointense on T1-weighted images (T1WI) and heterogeneously hypointense on T2-weighted images (T2WI), with faint, gradual peripheral enhancement on dynamic contrast-enhanced (DCE) MRI. The neoplasm consisted of fibroblast-type fusiform cells in a matrix of myxoid material and collagen. Case 2 was a 47-year-old man with a 10-year history of a slow-growing tumor on his right second toe. A radiograph revealed a non-calcified soft-tissue tumor with cortical erosion of the underlying distal phalanx. The tumor was hypointense on T1WI and a heterogeneous mixture of slight hyperintensity and hypointensity on T2WI, with heterogeneous enhancement on contrast-enhanced T1WI. The tumor consisted of spindle and stellate cells in an abundant myxoid matrix. Although rare, radiologists should be aware that the MRI features of SAFM are non-specific as they depend on the variable proportions of fibrous and myxoid stroma and consider them in the differential diagnosis of any slow-growing firm tumor located in the periungual or subungual regions of the fingers and toes in adult patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00256-025-04964-9 | DOI Listing |
In Vivo
August 2025
Section of Orthopaedic Surgery, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan
Superficial angiomyxoma (SAM) is a rare benign mesenchymal tumor of uncertain differentiation that primarily occurs in the trunk, lower extremities and head and neck of middle-aged adults. It typically presents as a slow-growing, painless polypoid or papulonodular lesion. Ultrasonography shows an ovoid, well-defined mass with a homogeneous, hypoechoic echotexture.
View Article and Find Full Text PDFJAMA
August 2025
University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, Pennsylvania.
Importance: Melanoma, the fifth most common cancer in the US, has increased from 8.8 per 100 000 in 1975 to 28.42 per 100 000 in 2022.
View Article and Find Full Text PDFBMC Public Health
August 2025
Department of Molecular Imaging, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Introduction: The COVID-19 pandemic significantly disrupted healthcare systems worldwide. Prioritizing emergency responses resulted in the postponement of routine medical care, including melanoma diagnoses. We performed a systematic review and meta-analysis to quantify the pandemic's effect on diagnosis rates, Breslow thickness, stage at presentation, ulceration, histologic subtypes, and patient age.
View Article and Find Full Text PDFHistopathology
August 2025
Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Cancer Treat Res Commun
September 2025
Internal Medicine Department, South Medica Hospital, Puente de Piedra 150 14050, Mexico City, Mexico; Oncology Department, The National Institute of Respiratory Diseases, Calz. De Tlalpan 4502 14080, Mexico City, Mexico. Electronic address:
Background: Melanoma is currently the most aggressive skin cancer. It is currently categorized based on mutations that have been studied for their prognostic relevance.
Objective: Define the epidemiology of mutations in patients with melanoma in Mexico using the Next-Generation Sequencing technology and explore its prognosis utility in terms of prognosis.